Search

everythinglearnresearchcommunity

for

Search:↓

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

DHEA boosts bone cell growth and differentiation in elderly stem cells.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Local estrogen synthesis in skin may improve wound healing.

Early puberty is more common in girls and African-American children, possibly due to nutrition, obesity, stress, and environmental factors, and is treated with hormone therapy.

Finasteride is made through a series of chemical reactions starting from a specific intermediate compound.

Sports supplements can cause skin problems and may contain harmful substances.

A new antiandrogen compound was made and its detailed three-dimensional shape was described.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Normal androgen levels need ACTH, and different mechanisms control adrenarche and gonadarche.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Alloxan diabetes, methylthiouracil, cortisone, and adrenaline affect how white mice hair follicles use glucose and cystine and their cell division.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Synthetic hormone treatment reduces melanin and hair growth in rats.

Chronic DHEA supplementation slightly increases testosterone in hair but stays within safe limits.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Human beard hair follicles change testosterone into other related hormones, but don't much change androstenedione into testosterone.

A new minoxidil-like substance, triaminodil, was found in an illegal hair growth supplement.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.